These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11837249)

  • 1. Discrepancies between chained and classic utilities induced by anchoring with occasional adjustments.
    Stalmeier PF
    Med Decis Making; 2002; 22(1):53-64. PubMed ID: 11837249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS.
    Schackman BR; Goldie SJ; Freedberg KA; Losina E; Brazier J; Weinstein MC
    Med Decis Making; 2002; 22(1):27-38. PubMed ID: 11833663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of classic utilities to published pediatric cost-utility studies.
    Finnell SM; Carroll AE; Downs SM
    Acad Pediatr; 2012; 12(3):219-28. PubMed ID: 22075466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correcting biases in standard gamble and time tradeoff utilities.
    van Osch SM; Wakker PP; van den Hout WB; Stiggelbout AM
    Med Decis Making; 2004; 24(5):511-7. PubMed ID: 15359000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valuing Treatments for Parkinson Disease Incorporating Process Utility: Performance of Best-Worst Scaling, Time Trade-Off, and Visual Analogue Scales.
    Weernink MG; Groothuis-Oudshoorn CG; IJzerman MJ; van Til JA
    Value Health; 2016; 19(2):226-32. PubMed ID: 27021757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The validity of time trade-off values in calculating QALYs: constant proportional time trade-off versus the proportional heuristic.
    Dolan P; Stalmeier P
    J Health Econ; 2003 May; 22(3):445-58. PubMed ID: 12683961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of patients' preferences for chemotherapy: the impact of experience.
    Jansen SJ; Kievit J; Nooij MA; Stiggelbout AM
    Med Decis Making; 2001; 21(4):295-306. PubMed ID: 11475386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The construction of standard gamble utilities.
    van Osch SM; Stiggelbout AM
    Health Econ; 2008 Jan; 17(1):31-40. PubMed ID: 17410521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of anchor point on utilities for 5 common ophthalmic diseases.
    Lee BS; Kymes SM; Nease RF; Sumner W; Siegfried CJ; Gordon MO
    Ophthalmology; 2008 May; 115(5):898-903.e4. PubMed ID: 17826833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the multi-attribute Adolescent Health Utility Measure (AHUM).
    Beusterien KM; Yeung JE; Pang F; Brazier J
    Health Qual Life Outcomes; 2012 Aug; 10():102. PubMed ID: 22929184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' utilities for cancer treatments: a study of the chained procedure for the standard gamble and time tradeoff.
    Jansen SJ; Stiggelbout AM; Wakker PP; Vliet Vlieland TP; Leer JW; Nooy MA; Kievit J
    Med Decis Making; 1998; 18(4):391-9. PubMed ID: 10372581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis.
    Melnikow J; Birch S; Slee C; McCarthy TJ; Helms LJ; Kuppermann M
    Med Care; 2008 Sep; 46(9):946-53. PubMed ID: 18725849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health utilities in gynecological oncology and mastology in Germany.
    Hildebrandt T; Thiel FC; Fasching PA; Graf C; Bani MR; Loehberg CR; Schrauder MG; Jud SM; Hack CC; Beckmann MW; Lux MP
    Anticancer Res; 2014 Feb; 34(2):829-35. PubMed ID: 24511019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring utilities of severe facial disfigurement and composite tissue allotransplantation of the face in patients with severe face and neck burns from the perspectives of the general public, medical experts and patients.
    Chuback J; Yarascavitch B; Yarascavitch A; Kaur MN; Martin S; Thoma A
    Burns; 2015 Nov; 41(7):1524-31. PubMed ID: 26068209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the measurement of health utilities in published cost-utility analyses.
    Brauer CA; Rosen AB; Greenberg D; Neumann PJ
    Value Health; 2006; 9(4):213-8. PubMed ID: 16903990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new explanation for the difference between time trade-off utilities and standard gamble utilities.
    Bleichrodt H
    Health Econ; 2002 Jul; 11(5):447-56. PubMed ID: 12112493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma.
    Blumenschein K; Johannesson M
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):189-94. PubMed ID: 9494453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of health states after stroke: a systematic review of the literature.
    Post PN; Stiggelbout AM; Wakker PP
    Stroke; 2001 Jun; 32(6):1425-9. PubMed ID: 11387509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient participation in clinical decision-making for treatment of T3 laryngeal cancer: a comparison of state and process utilities.
    van der Donk J; Levendag PC; Kuijpers AJ; Roest FH; Habbema JD; Meeuwis CA; Schmitz PI
    J Clin Oncol; 1995 Sep; 13(9):2369-78. PubMed ID: 7666096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.